Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letters to Editor
  • Published:

Chemical Carcinogenesis in Mice inhibited by Interferon

Abstract

SEVERAL experiments have demonstrated that the anti-viral substance, interferon, can inhibit the growth of spontaneous1,2, transplanted3 and virus-induced neoplasms in mice4–7. Lieberman et al.5 reported that interferon treatment partially suppressed X-radiation-induced leukaemia in C57B1/6 mice. As they pointed out, the inhibitory effect provided additional evidence for the theory that X-rays cause lymphoma through the activation of a leukaemogenic type C RNA viral intermediate. In this communication, we report studies with CF-1 mice (Carworth Farms, New York City) to determine the effects of interferon on SC tumour induction by 3-methylcholanthrene (3-MC). These mice were previously shown to harbour high levels of type C RNA gs antigen and.infectious virus in normal spleens and in induced tumours, while spontaneous tumours rarely develop until late in life8–10.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Came, P. E., & Moore, D. H., Proc. Soc. Exp. Biol. Med., 137, 304 (1971).

    Article  CAS  PubMed  Google Scholar 

  2. Gresser, I., Coppey, J., & Bourali, C., J. Nat. Cancer Inst., 43, 1083 (1969).

    CAS  PubMed  Google Scholar 

  3. Gresser, I., & Bourali, C., J. Nat. Cancer Inst., 45, 365 (1970).

    CAS  PubMed  Google Scholar 

  4. De Clercq, E., and De Somer, P., J. Nat. Cancer Inst., 47, 1345 (1971).

    CAS  PubMed  Google Scholar 

  5. Lieberman, M., Merigan, T. C., & Kaplan, H. S., Proc. Soc. Exp. Biol. Med., 138, 575 (1971).

    Article  CAS  PubMed  Google Scholar 

  6. Berman, L. D., Nature, 227, 1349 (1970).

    Article  CAS  PubMed  Google Scholar 

  7. Rhim, J. S., & Huebner, R. J., Proc. Soc. Exp. Biol. Med., 136, 524 (1971).

    Article  CAS  PubMed  Google Scholar 

  8. Huebner, R. J., & Todaro, G. J., Proc. US Nat. Acad. Sci., 64, 1087 (1969).

    Article  CAS  Google Scholar 

  9. Whitmire, C. E., Salerno, R. A., Rabstein, L. S., Huebner, R. J., & Turner, H. C., J. Nat. Cancer Inst., 47, 1255 (1971).

    CAS  PubMed  Google Scholar 

  10. Hartley, J. W., Rowe, W. P., Capps, W. I., & Huebner, R. J., Proc. US Nat. Acad. Sci., 53, 931 (1965).

    Article  CAS  Google Scholar 

  11. Gresser, I., Bourali, C., ChourouIinkov, I., Fontaine-Brouty-Boye, D., & Thomas, M. T., Ann. NY Acad. Sci., 173, 694 (1970).

    Article  CAS  Google Scholar 

  12. Gresser, I., Fountaine-Brouty-Boye, D., Thomas, M. T., & Macieira-Coelbo, A., Proc. US Nat. Acad. Sci., 66, 1052 (1970).

    Article  CAS  Google Scholar 

  13. Gresser, I., & Bourali-Maury, C., Nature New Biology, 236, 78 (1972).

    Article  CAS  PubMed  Google Scholar 

  14. Lindall, P., Leary, P., & Gresser, I., Proc. US Nat. Acad. Sci., 69, 721 (1972).

    Article  Google Scholar 

  15. Huang, K. Y., Donahoe, R. M., Gordon, F. B., & Dressier, H. R., Infect. Immunity, 4, 581 (1971).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

SALERNO, R., WHITMIRE, C., GARCIA, I. et al. Chemical Carcinogenesis in Mice inhibited by Interferon. Nature New Biology 239, 31–32 (1972). https://doi.org/10.1038/newbio239031a0

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1038/newbio239031a0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing